Home › PMT CORPORATION › INTEGRA®
INTEGRA®
PMT CORPORATION · Model 3612ES-16L-I · UDI-DI 00650551003434
LCJ
Prescription
1
510(k) clearances
5,147
Adverse events (4 deaths)
21
Recalls
22
Facilities
Description
INTEGRA TE, CRESCENT, ENHANCED SURFACE, BREAST, INTERNAL PORT 500CC, 11.3X16CM, 6.3CM PROJECTION
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-18 | Mentor Texas, LP. | Infusion sets may contain dull/blunt needle tip, which may be difficult to advance, and/or break. |
| 2026-02-02 | B Braun Medical Inc | The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. |
| 2026-02-02 | B Braun Medical Inc | The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. |
| 2026-02-02 | B Braun Medical Inc | The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
